Hormonal fluctuations can act as triggers for mood disorders in women when an underlying sensitivity to reproductive hormones exists. Research by Katherine L. Wisner at the University of Pittsburgh has linked changes around childbirth to increased risk of major depressive episodes, while David R. Rubinow at the University of North Carolina has characterized premenstrual dysphoric disorder as an emotional response to normal cyclical hormone shifts rather than a hormone deficiency. The World Health Organization reports that biological and social factors together determine population-level patterns of mental health in women.
Biological mechanisms
Estrogen and progesterone influence brain circuits that regulate mood through multiple pathways. Estrogen modulates serotonin synthesis, receptor expression, and synaptic plasticity, and progesterone and its metabolites act on GABAergic signaling, which affects anxiety and emotional regulation. Changes in these systems during the menstrual cycle, after delivery, or in perimenopause can destabilize neural networks in susceptible individuals. Rubinow and colleagues emphasize the concept of hormonal sensitivity where identical endocrine changes produce markedly different mood outcomes across women, implicating genetic, epigenetic, and prior stress exposures as moderators.
Timing, causes, and consequences
Specific reproductive windows carry higher risk. The late luteal phase can precipitate premenstrual dysphoric disorder in a minority of women, childbirth is a major risk period for postpartum depression with substantial functional impact as described by Wisner, and the menopausal transition is associated with elevated depressive symptoms for some individuals. Causes are multifactorial: abrupt hormonal withdrawal, altered neuroinflammation, dysregulated hypothalamic-pituitary-adrenal axis responses, and social determinants such as insufficient support or culturally mediated stigma all contribute. Consequences extend beyond individual suffering to affect maternal-infant bonding, occupational performance, and community health; cultural practices around childbirth and territorial disparities in access to mental health care shape outcomes.
Clinical and public health responses therefore focus on recognizing temporal links between hormone changes and mood, screening high-risk women, and using interventions that target both biology and context. Evidence-based approaches include pharmacotherapy that addresses monoaminergic systems, psychosocial interventions, and, in selected cases, hormonal strategies guided by specialists. Individual assessment is crucial because identical hormonal events can be benign for many women while precipitating severe illness in others.